{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:14:02Z","timestamp":1791209642726,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/ico.0b013e318242fd60","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T10:15:01Z","timestamp":1333534501000},"page":"1000-1008","source":"Crossref","is-referenced-by-count":166,"title":["Clinical Utility of Objective Tests for Dry Eye Disease"],"prefix":"10.1097","volume":"31","author":[{"given":"Benjamin D.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Crews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar\u015f","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"de la Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Comert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Charoenrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline L.","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Pepose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie P.","family":"Kosheleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Lemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210204","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1167\/iovs.10-5390","article-title":". An objective approach to dry eye disease severity.","volume":"51","author":"Sullivan","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R2-7-20210204","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archopht.1961.01840020511008","article-title":"The total osmotic pressure of tears in normal and various pathologic conditions.","volume":"65","author":"Mastman","year":"1961","journal-title":"Arch Ophthalmol"},{"key":"R3-7-20210204","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00003226-199603000-00002","article-title":". Model for ocular tear film function.","volume":"15","author":"Mathers","year":"1996","journal-title":"Cornea"},{"key":"R4-7-20210204","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1167\/iovs.08-2689","article-title":". A link between tear instability and hyperosmolarity in dry eye.","volume":"50","author":"Liu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-7-20210204","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.ICL.0000162759.79740.46","article-title":". Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface.","volume":"31","author":"Luo","year":"2005","journal-title":"Eye Contact Lens"},{"key":"R7-7-20210204","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/ICO.0b013e318030d259","article-title":"Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways.","volume":"26","author":"Luo","year":"2007","journal-title":"Cornea"},{"key":"R8-7-20210204","first-page":"65","article-title":"2007 Report of the Dry Eye WorkShop.","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R9-7-20210204","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/978-1-4615-2417-5_89","article-title":"Changes in tear ion concentrations in dry-eye disorders.","volume":"350","author":"Gilbard","year":"1994","journal-title":"Adv Exp Med Biol"},{"issue":"suppl 2","key":"R10-7-20210204","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/S0039-6257(00)00201-0","article-title":"Diagnosis of dry eye.","volume":"45","author":"Bron","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"R11-7-20210204","first-page":"495","article-title":"Tear osmolaritya new gold standard Adv Exp Med Biol.","volume":"350","author":"Farris","year":"1994","journal-title":""},{"key":"R13-7-20210204","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/02713683.2010.484557","article-title":"Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.","volume":"35","author":"Versura","year":"2010","journal-title":"Curr Eye Res"},{"key":"R14-7-20210204","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/ICO.0b013e3181cd9a1d","article-title":"Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques.","volume":"29","author":"Tomlinson","year":"2010","journal-title":"Cornea"},{"key":"R15-7-20210204","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1167\/iovs.09-4596","article-title":". Tear osmolarity as a biomarker for dry eye disease severity.","volume":"51","author":"Suzuki","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-7-20210204","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00003226-200007000-00016","article-title":"Survey of preferred tests for diagnosis of the tear film and dry eye.","volume":"19","author":"Korb","year":"2000","journal-title":"Cornea"},{"key":"R17-7-20210204","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":". Reliability and validity of the ocular surface disease index.","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R18-7-20210204","first-page":"221","article-title":"Report of the National Eye InstituteIndustry workshop on clinical trials in dry eyes.","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"R19-7-20210204","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1542-0124(12)70139-8","article-title":"Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading.","volume":"1","author":"Foulks","year":"2003","journal-title":"Ocul Surf"},{"key":"R20-7-20210204","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","article-title":"Diagnostic tests in the Sicca syndrome.","volume":"82","author":"van Bijsterveld","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"R21-7-20210204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/HYPERTENSIONAHA.107.090084","article-title":". Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects.","volume":"50","author":"Tatasciore","year":"2007","journal-title":"Hypertension"},{"key":"R22-7-20210204","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bjo.2010.182758","article-title":". Long-term perimetric fluctuation in patients with different stages of glaucoma.","volume":"95","author":"Fogagnolo","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R23-7-20210204","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archopht.1983.01040010557003","article-title":"Increased tear evaporation in eyes with keratoconjunctivitis sicca.","volume":"101","author":"Rolando","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"R24-7-20210204","first-page":"4174","article-title":". Impact of Time Between Collection on Human Tear Film Fluid Osmolarity.","volume":"51","author":"Keech","year":"2010","journal-title":"ARVO"},{"key":"R25-7-20210204","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1249\/MSS.0b013e31820e7cb6","article-title":". Tear fluid osmolarity as a potential marker of hydration status.","volume":"43","author":"Fortes","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"R26-7-20210204","first-page":"3379","article-title":". Longitudinal Variability of Tear Film Osmolarity in Normal and Dry Eye Patients.","volume":"51","author":"Eldridge","year":"2010","journal-title":"ARVO"},{"key":"R27-7-20210204","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archopht.1988.01060130530029","article-title":"Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.","volume":"106","author":"Nelson","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R28-7-20210204","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1167\/iovs.05-1504","article-title":". Tear film osmolarity: determination of a referent for dry eye diagnosis.","volume":"47","author":"Tomlinson","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-7-20210204","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3945\/jn.109.118901","article-title":". Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye.","volume":"140","author":"Larmo","year":"2010","journal-title":"J Nutr"},{"key":"R30-7-20210204","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1167\/iovs.08-2476","article-title":"Li de Q, et al.. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome.","volume":"50","author":"Chotikavanich","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R31-7-20210204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.85.2.147","article-title":". Tear film MMP accumulation and corneal disease.","volume":"85","author":"Smith","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R32-7-20210204","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000150445","article-title":". Inflammatory markers in the tears of patients with ocular surface disease.","volume":"40","author":"Acera","year":"2008","journal-title":"Ophthalmic Res"},{"key":"R33-7-20210204","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1167\/iovs.05-0735","article-title":". Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dye.","volume":"47","author":"Argueso","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R34-7-20210204","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/978-1-4615-0717-8_157","article-title":". Alternative reference values for tear film break up time in normal and dry eye populations.","volume":"506","author":"Abelson","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"R35-7-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":". Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"R36-7-20210204","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group.","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"R37-7-20210204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clae.2010.01.003","article-title":". Tear osmolarity measurement using the TearLab osmolarity system in the assessment of dry eye treatment effectiveness.","volume":"33","author":"Benelli","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"key":"R38-7-20210204","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/ICO.0b013e3181c11e45","article-title":". Diurnal variation of visual function and the signs and symptoms of dry eye.","volume":"29","author":"Walker","year":"2010","journal-title":"Cornea"},{"key":"R39-7-20210204","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1542-0124(12)70299-9","article-title":". Predicted phenotypes of dry eye: proposed consequences of its natural history.","volume":"7","author":"Bron","year":"2009","journal-title":"Ocul Surf"},{"key":"R40-7-20210204","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.preteyeres.2009.11.002","article-title":". A mass and solute balance model for tear volume and osmolarity in the normal and the dry eye.","volume":"29","author":"Gaffney","year":"2010","journal-title":"Prog Retin Eye Res"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-201209000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:34:55Z","timestamp":1786048495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-201209000-00007"}},"subtitle":["Variability Over Time and Implications for Clinical Trials and Disease Management"],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318242fd60","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}